By G HossainPosted on December 17, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs 2026 is set to be a banner year for M&A in biopharma, as buyers facing major patent cliffs fight for a small pool of late-stage assets. Pharmas Write Big M&A Checks Again as Patent Urgency Seizes C-Suites Post navigation 6 Biotechs That Could Be Big Pharma’s Next M&A TargetAddition Debuts With $100M to Advance One-Time Therapies for Rare, Chronic Diseases